South Dakota SB 113: add nabiximols as a Schedule III controlled substance.

Status: Senate Tabled , Passed, YEAS 32, NAYS 3 S.J. 196 (as of 2022-02-07)

State: South Dakota · Session: 2022 · Bill: SB 113

Subjects: Controlled Substances

Sponsors: Crabtree, Davis, Tobin

View South Dakota SB 113 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.